After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Regeneron Pharmaceuticals, Inc is $77.61B. A total of 0.88 million shares were traded on the day, compared to an average of 893.12K shares.
In the most recent transaction, McCourt Marion sold 1,000 shares of REGN for 844.61 per share on Nov 01 ’24. After the transaction, the EVP Commercial now owns 12,931 company shares. In a previous transaction on Nov 01 ’24, MARION E MCCOURT bought 1,000 shares at 844.61 per share.
Among the insiders who sold shares, RYAN ARTHUR F disposed of 100 shares on Oct 01 ’24 at a per-share price of $1048.78. This resulted in the Director holding 17,582 shares of REGN after the transaction. In another insider transaction, McCourt Marion sold 1,000 shares at $1054.06 per share on Oct 01 ’24. Company shares held by the EVP Commercial now total 12,931.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. REGN’s most recent ex-dividend date was 0.53% when it declared a $0.88 quarterly dividend that was paid in cash on 2/20/2025.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, REGN has a high of $1211.20 and a low of $642.00.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. REGN’s latest balance sheet shows that the firm has $5.69B in Cash & Short Term Investments as of fiscal 2021. There were $2.70B in debt and $3.93B in liabilities at the time. Its Book Value Per Share was $267.82, while its Total Shareholder’s Equity was $18.77B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for REGN is Buy with a score of 4.46.
